Search Results 591-600 of 17146 for egfr

1. Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS) - Mayo Clinic

   ... (eGFR) \<60 ml/min/1.73m2) based on medical history, physical exam, laboratory studies, and/or electrocardiogram (ECG) performed during screening period 5 ...

2. A Study to Assess Dendritic Cell Immunotherapy Plus Standard-of-Care to Treat Advanced Renal Cell Carcinoma - Mayo Clinic

   rate (eGFR) 30 mL/min 10. Adequate hepatic function, as defined by both of the following: 1. Total serum bilirubin 1.5 x ULN 2. Aspartate aminotransferase ...

3. A Phase 1 Trial of MK-4280 as Monotherapy and in Combination with Pembrolizumab with or without Chemotherapy or Lenvatinib (E7080/MK 7902) in Subjects with Advanced Solid Tumors - Mayo Clinic

   Subjects eligible to receive EGFR-targeted therapy must have previously received this treatment in order to be eligible for the study. Note – Subjects with ...

4. A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients with CAA - Mayo Clinic

   Estimated glomerular filtration (eGFR) of <30mL/min/1.73m2 (calculation will be based on the Chronic Kidney Disease Epidemiology Collaboration [CKD-EPI] ...

5. A Global Phase III Study Of Rilvegostomig Or Pembrolizumab Plus Chemotherapy For First-Line Treatment Of Metastatic Non-squamous NSCLC - Mayo Clinic

   * Absence of sensitizing EGFR mutations (including, but not limited to, exon 19 deletion and exon 21 L858R, exon 21 L861Q, exon 18 G719X, and exon 20 S768I ...

6. A Study of AO-176 as Monotherapy Combinated with Bortezomib and Dexamethasone in Adults with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   eGFR (CKD-EPI calculation) ≥ 30 mL/min/1.73m^2. Hepatic: Serum total bilirubin ≤ 1.5 x ULN; or; Direct bilirubin ≤ ULN for patients with total bilirubin ...

7. Extension Study Of ACT-EARLY - Mayo Clinic

   Stage IV or V chronic kidney disease (corresponding to an eGFR ≤ 29 mL/min/1.73 m2), or undergoing renal dialysis, or recipient of a kidney transplant.

8. A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer - Mayo Clinic

   Estimated glomerular filtration rate (eGFR) ≥ 50 mL/min/1.73 m^2 using the Modification of Diet in Renal Disease (MDRD) study equation. International ...

9. Laryngeal (Voice Box) Cancer Clinical Trials - Mayo Clinic Research

   The purpose of this study is to demonstrate the safety and tolerability of JAB-3312 in combination with anti-PD-1 mAb or MEKi or KRASi or EGFR-TKI in patients ...

10. A Study of Donor-Alloantigen-Reactive Regulatory T Cell Therapy with an Immunosuppression Regimen in Adult Liver Transplantation - Mayo Clinic

    Calculated glomerular filtration rate (eGFR) less than 40 ml/min per MDRD4 equation within 10 days prior to infusion. Participating Mayo Clinic locations.